Skip to main content
. Author manuscript; available in PMC: 2013 Sep 9.
Published in final edited form as: J Immunol. 2010 Sep 15;185(8):4750–4759. doi: 10.4049/jimmunol.1000769

FIGURE 1.

FIGURE 1

Mutant TGF-β1/Fc fusion protein gene construction. Scheme for the genetic fusion of mutant human TGF-β1 and Fcγ4 cDNAs to create a TGF-β1/Fc immunoligand. Mutations were made in the pro region of TGF-β1 precursor by using site-directed mutagenesis to replace Cys33, Cys223 and Cys225 with Ser residues, which render TGF-β1/Fc immunoligand biologically active.